Human papillomavirus type 16 viral load measurement as a predictor of infection clearance

Journal of General Virology

Volumn 94, Issue PART8, 2013, Pages 1850-1857

  Trevisan, Andrea ^a,b   Schlecht, Nicolas F ^c   Ramanakumar, Agnihotram V ^d   Villa, Luisa L ^a,e,f   Franco, Eduardo L ^d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f Saõ Paulo Santa Casa Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COPY NUMBER VARIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PATHOGEN CLEARANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRAL CLEARANCE; VIRUS LOAD;

FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84880146577     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.051722-0     Document Type: Article

References (32)

1. Bauer, H. M., Ting, Y., Greer, C. E., Chambers, J. C., Tashiro, C. J., Chimera, J., Reingold, A. & Manos, M. M. (1991). Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265, 472-477.
2. Bavin, P. J., Giles, J. A., Deery, A., Crow, J., Griffiths, P. D., Emery, V. C. & Walker, P. G. (1993). Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 67, 602-605.
3. Bernard, H. U., Chan, S. Y., Manos, M. M., Ong, C. K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M. & Wheeler, C. M. (1994). Identification and assessment of known and novel human papilla-maviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170, 1077-1085.
4. Bryan, J. T., Taddeo, F., Skulsky, D., Jansen, K. U., Frain, B. M., Qadadri, B. & Brown, D. R. (2006). Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas. J Med Virol 78, 117-124.
5. Bulkmans, N. W POBASCAM Study Group (2007). High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 96, 1419-1424.
6. Caballero, O. L., Villa, L. L. & Simpson, A. J. G. (1995). Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation. Nucleic Acids Res 23, 192-193.
7. Farthing, A., Masterson, P., Mason, W. P. & Vousden, K. H. (1994). Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 47, 649-652.
8. Fontaine, J., Gravitt, P., Duh, L. M., Lefevre, J., Pourreaux, K., Hankins, C. & Coutlée, F. (2005). High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens. Cancer Epidemiol Biomarkers Prev 14, 2200-2207.
9. Franco, E Ludwig-McGill Study Group (1999). Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Rev Panam Salud Publica 6, 223-233.
10. Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R. & Apple, R. J. (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol 38, 357-361.
11. Gravitt, P. E., Burk, R. D., Lorincz, A., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M. C., Rodriguez, A. C., Helzlsouer, K. J. & Schiffman, M. (2003). A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12, 477-484.
12. Gravitt, P. E., Kovacic, M. B., Herrero, R., Schiffman, M., Bratti, C., Hildesheim, A., Morales, J., Alfaro, M., Sherman, M. E. & other authors (2007). High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121, 2787-2793.
13. Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P. & other authors (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169, 235-240.
14. Iftner, T. & Villa, L. L. (2003). Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 31, 80-88.
15. Iftner, T., Germ, L., Swoyer, R., Kjaer, S. K., Breugelmans, J. G., Munk, C., Stubenrauch, F., Antonello, J., Bryan, J. T. & Taddeo, F. J. (2009). Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays. J Clin Microbiol 47, 2106-2113.
16. Jacobs, M. V., Walboomers, J. M., van Beek, J., Voorhorst, F. J., Verheijen, R. H., Meijer, C. J., van den Brule, A. J., Helmerhorst, T. J. & Snijders, P. J. (1999). A quantitative polymerase chain reaction enzyme immunoassay for accurate measurements of human papilloma virus type 16 DNA levels in cervical scrapings. Br J Cancer 81, 114-121.
17. Klein, R. S., Ho, G. Y., Vermund, S. H., Fleming, I. & Burk, R. D. (1994). Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 170, 1404-1409.
18. Manos, M. M., Ting, Y., Wrigth, D. K., Lewis, A. J., Broker, T. R. & Wolinsky, S. M. (1989). The use of polymerase chain reaction amplification for the detection of genital human papillomaviroses. In Molecular Diagnostic of Human Cancer, Cancer Cells, pp. 209-214. Edited by M. Furth & M. Greaves. New York, NY: Cold Spring Harbor Press.
19. Mincheva, A., Gissmann, L. & zur Hausen, H. (1987). Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (Berl) 176, 245-256.
20. Morris, B. J. (2005). Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region. Clin Chem Lab Med 43, 1171-1177.
21. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B. & Erlich, H. A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
22. Schlecht, N., Trevisan, A., Rohan, T., Ferenczy, A., Villa, L. L. & Franco, E. L. (2001a). Viral load as a predictor of lesion grade severity in cervical intraepithelial neoplasia. In Program and Oral Presentations for 19th International Papillomavirus Conference, Florianópolis, Santa Catarina, Brazil, p. 138, O-93.
23. Schlecht, N. F., Kulaga, S., Robitaille, J., Ferreira, S., Santos, M., Miyamura, R. A., Duarte-Franco, E., Rohan, T. E., Ferenczy, A. & other authors (2001b). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286, 3106-3114.
24. Schlecht, N. F., Trevisan, A., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L. & Franco, E. L. (2003). Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103, 519-524.
25. Trottier, H., Mahmud, S., Prado, J. C., Sobrinho, J. S., Costa, M. C., Rohan, T. E., Villa, L. L. & Franco, E. L. (2008). Type-specific duration of human papillomavirus infection: implications for human papilla mavirus screening and vaccination. J Infect Dis 197, 1436-1447.
26. van den Brule, A. J. C., Snijders, P. J. F., Gordijn, R. L., Bleker, O. P., Meijer, C. J. L. M. & Walboomers, J. M. M. (1990). General primer mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 45, 644-649.
27. Wentzensen, N., Schiffman, M., Dunn, T., Zuna, R. E., Gold, M. A., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S. & other authors (2009). Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125, 2151-2158.
28. Wentzensen, N., Gravitt, P. E., Long, R., Schiffman, M., Dunn, S. T., Carreon, J. D., Allen, R. A., Gunja, M., Zuna, R. E. & other authors (2012). Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol 50, 1564-1570.
29. Wright, D. K. & Manos, M. M. (1990). Sample preparation from paraffin-embedded tissues. In PCR Protocols: a Guide to Methods and Applications, pp. 153-158. Edited by M. A. Innis, D. H. Gelfand, J. J. Sninsky & T. J. White. San Diego: Academic Press.
30. Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. & Howley, P. M. (1985). Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119, 361-366.
31. Ylitalo, N., Sørensen, P., Josefsson, A. M., Magnusson, P. K., Andersen, P. K., Pontén, J., Adami, H. O., Gyllensten, U. B. & Melbye, M. (2000). Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355, 2194-2198.
32. zur Hausen, H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350.